Peak, J., Goranitis, I., Day, E., Copello, A., Freemantle, N. and Frew, E., 2018. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health and quality of life outcomes, 16(1), p.106.
Andronis, L., Goranitis, I., Bayliss, S. and Duarte, R., 2018. Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review. PharmacoEconomics, 36(3), p.301.
Lissauer, D., Wilson, A., Daniels, J., Middleton, L., Bishop, J., Hewitt, C., Merriel, A., Weeks, A., Mhango, C., Mataya, R., Taulo, F. et al., 2018. Prophylactic antibiotics to reduce pelvic infection in women having miscarriage surgery–The AIMS (Antibiotics in Miscarriage Surgery) trial: study protocol for a randomized controlled trial. Trials, 19(1), p.245.
Day, E., Copello, A., Seddon, J.L., Christie, M., Bamber, D., Powell, C., Bennett, C., Akhtar, S., George, S., Ball, A., Frew, E., Goranitis, I., and Freemantle, N. 2018. A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services. BMC psychiatry, 18(1), p.8.
Goranitis I., Daley AJ, Stokes-Lampard H, Roalfe AK, Bellanca L and Jowett S. Aerobic exercise for vasomotor menopausal symptoms: a cost-utility analysis based on the Active Women trial. Accepted in PLoS ONE.
Coast J., Mitchell, P., Goranitis I., Ethics and values in welfarism and extra-welfarism IN: Razzouk D. Mental Health Economics - The Costs and Benefits of Psychiatric Care. Springer International Publishing. DOI 10.1007/978-3-319-55266-8; Hardcover ISBN 978-3-319-55265-1; eBook ISBN 978-3-319-55266-8.
Goranitis I., Coast J., Day E., Copello A., Freemantle N., and Frew E. Maximising health or sufficient capability in economic evaluation? A methodological experiment of treatment for drug addiction. Medical Decision Making: an international journal of the Society for Medical Decision Making 37.5 (2017): 498.
Rachaneni S., McCooty S., Middleton L.J., Brookes V.L., Daniels J.P., Coomarasamy A., Verghese T., Balogun M., Goranitis I., Barton P., Roberts T.E., Deeks J.J., Latthe P. Accuracy and economic evaluation of Bladder Ultrasound in the diagnosis of Detrusor Overactivity: a study to evaluate if ultrasound can reduce the need for urodynamics. NIHR Health Technology Assessment (HTA). 20.7 (2016): 1-150.
Goranitis I., Barton P., Middleton L., Deeks J.J., Daniels J., Coomarasamy A., Rachaneni S., McCooty S., Verghese T., Latthe P., and Roberts T.E. Testing and treating women with persistent symptoms of overactive bladder or mixed urinary incontinence: A model-based economic evaluation. PLoS ONE 11(8): e0160351. doi:10.1371/journal.pone.0160351(2016).
Latthe P.M., Middleton L., Rachaneni S., McCooty S., Daniels J., Coomarasamy A., Balogun M., Duckett J., Thakar R., Goranitis I., Roberts TE, and Deeks J.J. Ultrasound bladder wall thickness and detrusor overactivity: a multicentre test accuracy study. BJOG: An International Journal of Obstetrics & Gynaecology (2017).
James N., Pirrie S., Pope A., Barton D., Andronis L., Goranitis I., Billingham L. et al. TRAPEZE: A randomised controlled trial of the clinical and cost effectiveness of chemotherapy with zoledronic acid, strontium-89 or both, in men with bony metastatic castrate refractory prostate cancer. NIHR Health Technology Assessment (HTA). 20.53 (2016): 1-324.
Andronis L., Goranitis I. et al. Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. British Journal of Urology International (BJUI). DOI: 10.1111/bju.13549 (2016).
James N., Pirrie S., Pope A., Barton D., Andronis L., Goranitis I. et al. Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel with strontium-89, zoledronic acid, neither, or both. JAMA Oncol. 2.4(2016):493-499. doi:10.1001/jamaoncol.2015.5570.
Goranitis I., Coast J., Day E., Copello A., Freemantle N., Seddon J., Bennett C., Frew E. Measuring health and broader wellbeing benefits in the context of drug addiction: the psychometric performance of the ICECAP-A and EQ-5D-5L. Value in Health. 19.6 (2016): 820–828. doi:10.1016/j.jval.2016.04.010.
Goranitis I., Coast J., Al-Janabi H., Latthe P., and Roberts T.E. The validity and responsiveness of the ICECAP-A capability-wellbeing measure in women with overactive bladder symptoms. Quality of Life Research. 25.8 (2016): 2063–2075. doi 10.1007/s11136-015-1225-y.
Frempong S., Goranitis I., and Oppong R. Economic evaluation alongside factorial trials: a systematic review of empirical studies. Expert Review of Pharmacoeconomics & Outcomes Research. 15.5 (2015): 801-811.
Goranitis, I., Coast J., and Al-Janabi H. An investigation into the construct validity of the Carer Experience Scale (CES). Quality of Life Research (2014): 1-10.
Goranitis, I., Siskou O., and Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy 117.3 (2014): 279-284.
Liaropoulos L. and Goranitis I. Health care financing and the sustainability of health systems. International Journal for Equity in Health. 14.1 (2015): 80. DOI 10.1186/s12939-015-0208-5.
View all publications in research portal